S9 nonclinical evaluation for anticancer pharmaceuticals.

Author/creator International Conference on Harmonisation
Other author Center for Biologics Evaluation and Research (U.S.)
Format Electronic
Publication Info[Rockville, Md.?] : [U.S. Food and Drug Administration, Center for Biologics Evaluation and Research], [2009]
Description10 unnumbered pages : digital, PDF file.
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS110465
Subjects

Variant title Title from CBER guidelines Web page: Draft guidance on S9 nonclinical evaluation for anticancer pharmaceuticals
Portion of title Nonclinical evaluation for anticancer pharmaceuticals
General noteTitle from title screen (viewed on Mar. 20, 2009).
General note"2/13/2009"--CBER guidelines Web page.
Technical detailsMode of access: Internet at the FDA Web site. Address as of 3/20/09: http://www.fda.gov/cder/guidance/8681dft.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:AN 8

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available